Comparison Chart Evotec SE Deutsche Boerse AG
Stocks
EVT
DE0005664809
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.460 EUR | +0.93% |
|
+0.82% | -36.63% |
| 08-03 | Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 | CI |
| 08-03 | Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC SE | Other Biotechnology & Medical Research | +0.93% | +0.82% | -36.63% | -49.78% | -89.87% | 697M |
-
|
-
|
-
|
- Stock Market
- Stocks
- EVT Stock
- EVT Stock
- Charts Evotec SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
